Hostname: page-component-848d4c4894-p2v8j Total loading time: 0.001 Render date: 2024-06-03T03:06:31.204Z Has data issue: false hasContentIssue false
  • English
  • Français

Acute dystonic reaction with rivastigmine

Published online by Cambridge University Press:  08 April 2013

Vikas Dhikav  and
Kuljeet Singh Anand
Vikas Dhikav*
Affiliation:
Department of Neurology, Dr RML Hospital & Postgraduate Institute of Medical Education & Research, GGS-IP University, Baba Kharak Singh Marg, New Delhi, India110001
Kuljeet Singh Anand
Affiliation:
Department of Neurology, Dr RML Hospital & Postgraduate Institute of Medical Education & Research, GGS-IP University, Baba Kharak Singh Marg, New Delhi, India110001
*
Correspondence should be addressed to: Dr Vikas Dhikav, MBBS, MSc, MBA, PhD scholar, Department of Neurology, Dr RML Hospital & Postgraduate Institute of Medical Education & Research (PGIMER), GGS-IP University, Baba Kharak Singh Marg, New Delhi – 110001, India. Phone: +91-9868053977; +91-011-23741642. Email: vikasdhikav@hotmail.com.
Get access Rights & Permissions [Opens in a new window]

Abstract

Dystonic reactions are adverse extrapyramidal side effects and are common to antipsychotics, antiemetics, and a variety of other drugs. Rivastigmine, an anticholinesterase of carbamate variety, is well tolerated. A case of acute dystonic reaction with rivastigmine patch is being reported.

Keywords

dystoniadermal patchrivastigmineAlzheimer's disease
Type
Case Report
Information
International Psychogeriatrics , Volume 25 , Issue 8: Elder abuse an international perspective , August 2013 , pp. 1385 - 1386
Copyright
Copyright © International Psychogeriatric Association 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cossu, G., Melis, M., Melis, G., Maccioni, E., Putzu, V., Catte, O. and Putzu, P. F. (2004). Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report. Movment Disorders, 19, 1243–1244.CrossRefGoogle Scholar
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C. and Greenblatt, D. J. (1981). A method for estimating the probability of adverse drug reactions. Clinical Pharmacology & Therapeutics, 30, 239–245.CrossRefGoogle ScholarPubMed
Panagiotis, I., Pantelis, M., George, B. and Dimitris, K. (2012). Acute Pisa syndrome after administration of a single dose of donepezil. Journal of Neuropsychiatry & Clinical Neuroscienece, 24, 10026. doi:10.1176/appi.neuropsych.11070158.Google Scholar
Pavlis, C. J., Kutscher, E. C., Carnahan, R. M., Kennedy, W. K., Van Gerpen, S. and Schlenker, E. (2007). Rivastigmine-induced dystonia. Amrican Journal of Health System Pharmacy, 64, 2468–2470.CrossRefGoogle ScholarPubMed
Pope, A., Adams, C., Paton, C., Weaver, T. and Barnes, T. R. (2010). Assessment of adverse effects in clinical studies of antipsychotic medication: survey of methods used. British Journal of Psychiatry, 197, 67–72.CrossRefGoogle ScholarPubMed
Suzuki, T., Koizumi, J., Moroji, T., Sakuma, K., Hori, M. and Hori, T. (1990). Clinical characteristics of the Pisa syndrome. Acta Psychiatry Scandinavia, 82, 454–457.CrossRefGoogle ScholarPubMed